Chikungunya Assays

About InBios International

InBios International is a privately held, established leader in the infectious disease diagnostics market, with over 25 years of experience. The company leverages its expertise in immunodiagnostics to develop and manufacture a broad portfolio of tests, ranging from rapid point-of-care assays to ELISA kits, for both endemic and emerging pathogens. It has demonstrated agility in responding to public health crises, securing FDA EUAs for COVID-19 tests and government contracts for biothreat agents. With a state-of-the-art manufacturing facility in Seattle and strong regulatory credentials, InBios is positioned to address significant global diagnostic needs.

Therapeutic Areas

Other Chikungunya virus infection Drugs